Results 251 to 260 of about 195,338 (284)

Ad6-Based GM-CSF Expressing Vector Displays Oncolytic and Immunostimulatory Effects in an Immunocompetent Syrian Hamster Model of Cholangiocarcinoma. [PDF]

Viruses
Zabelina DS, Osipov ID, Maslov DE, Kovner AV, Vasikhovskaia VA, Demina DS, Romanov SE, Shishkina EV, Davydova J, Netesov SV, Romanenko MV.   +10 more
europepmc   +1 more source

Long-term survival in a patient with leptomeningeal metastases from non-small cell lung cancer treated with stereotactic radiotherapy (SRT), programmed cell death protein 1 (PD-1) inhibitor, and granulocyte-macrophage colony-stimulating factor (GM-CSF): a case report. [PDF]

Transl Cancer Res
Huan J, Shan C, Gu H, Li Y, Qi W.
europepmc   +1 more source

Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy. [PDF]

J Immunother Cancer
Kang S, Mansurov A, Kurtanich T, Chun HR, Slezak AJ, Volpatti LR, Chang K, Wang T, Alpar AT, Refvik KC, Hansen OI, Borjas GJ, Berg BTK, Shim HN, Hultgren KT, Gomes S, Wang Y, Solanki A, Ishihara J, Swartz MA, Hubbell JA.   +20 more
europepmc   +1 more source

NOTCH1 promotes the elevation of GM-CSF and IL-6 through the EZH2/STAT3 pathway to facilitate the fibrotic state of the myocardium in DLBCL. [PDF]

PLoS One
Zhang H, Dong W, Zhang L, Ma B, Wang J, Shen Y, Zhao D, Yin W, Li Y, Liu Q.   +9 more
europepmc   +1 more source

Reply: “Leigh Syndrome Due to the Variant c.1019T>C in COX15”

Movement Disorders Clinical Practice, EarlyView.
Haya S. AlFaris, Sangeetha Yoganathan, Marcus N. Callister, Liali Aljouda, Vivek Pai, Pradeep Krishnan, Andrea LeBlanc Miller, Christos Ganos, Carolina Gorodetsky   +8 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice

American Journal of Physiology-Lung Cellular and Molecular Physiology, 1999
Surfactant proteins and phospholipids accumulate in the alveolar spaces and lung tissues of mice deficient in granulocyte-macrophage colony-stimulating factor (GM-CSF), with pathological findings resembling the histology seen in the human disease pulmonary alveolar proteinosis (PAP).
J A, Reed, M, Ikegami, E R, Cianciolo, W, Lu, P S, Cho, W, Hull, A H, Jobe, J A, Whitsett   +7 more
openaire   +2 more sources

Incidence of GM-CSF Antibodies in Cancer Patients Receiving GM-CSF for Immunostimulation

Clinical Immunology, 2001
We have assessed the immunogenicity profile of GM-CSF in patients with either colorectal carcinoma (CRC) at different stages of disease or with multiple myeloma who were given recombinant human GM-CSF (Escherichia coli-derived) combination therapy. Metastatic CRC patients received a colon carcinoma-reactive antibody and high doses of GM-CSF (425--500 ...
G, Ullenhag, C, Bird, P, Ragnhammar, J E, Frödin, K, Strigård, A, OIsterborg, R, Thorpe, H, Mellstedt, M, Wadhwa   +8 more
openaire   +2 more sources

GM‐CSF and phorbol esters modulate GM‐CSF receptor expression by independent mechanisms

Journal of Cellular Physiology, 1991
AbstractHuman granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) (0.1 nM) down‐modulates its receptor in IL‐3/GM‐CSF dependent M‐07e cells, in KG‐1 cells and normal granulocytes, whereas phorbol esters 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) (2 nM) down‐modulates the GM‐CSF receptor in M‐07e cells and granulocytes but not in KG‐1 cells.
BRIZZI, Maria Felice, Arduino C, Avanzi GC, BUSSOLINO, Federico, PEGORARO, Luigi   +4 more
openaire   +3 more sources

GM-CSF in marrow transplantation

European Journal of Cancer, 1993
Bone marrow transplantation (BMT) is being increasingly used in a wide variety of diseases. During the period of re-engraftment the patient is particularly susceptible to a number of opportunistic infections which can radically affect acute morbidity and mortality.
openaire   +2 more sources

GM‐CSF‐induced acute eosinophilic pneumonia

British Journal of Haematology, 1995
Summary. There is increasing evidence that haemopoietic growth factors are effective in reversal of neutropenia associated with large granular lymphocytes (LGLs) proliferation. A 19‐year‐old woman with CD3+/TCRγδ+, CD4−, CD8− LGL proliferation and severe neutropenia repeatedly developed blood eosinophilia, fever and dyspnoea after administration of GM‐
J, Seebach, R, Speich, J, Fehr, P, Tuchschmid, E, Russi   +4 more
openaire   +2 more sources